Michael Powell insider trades

Open-market stock purchases and sales by Michael Powell, Director at Bicara Therapeutics Inc, from SEC Form 4 filings since Mar 17, 2010.

Recent trades

DateStockTradeValue
Jun 9, 2026BCAX Bicara Therapeutics IncBought (not open market)—

Companies traded

  • BCAX Bicara Therapeutics Inc: other filings, last Jun 9, 2026
  • GRTX Galera Therapeutics, Inc: other filings, last Jun 14, 2023
  • CMPI Checkmate Pharmaceuticals, Inc: 1 buy, last May 31, 2022
  • SYBX Synlogic, Inc: other filings, last Jun 5, 2019
  • OCRX Ocera Therapeutics, Inc: 3 buys, 3 sales, last Oct 31, 2016
  • MIRN Mirna Therapeutics, Inc: 1 buy, last Jun 29, 2016
  • TSRX Trius Therapeutics Inc: 1 buy, 4 sales, last Mar 26, 2012
  • OREX Orexigen Therapeutics, Inc: 24 sales, last Jun 2, 2011

Get free alerts when Michael Powell files a new trade →